ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "functional status"

  • Abstract Number: 2335 • ACR Convergence 2024

    Hand Function and Development of Psoriatic Arthritis in Skin Psoriasis Patients, a Prospective Cohort Study

    Birte Coppers1, Sara Bayat2, Koray Tascilar1, Daniela Bohr1, Larissa Valor1, David Simon3, Filippo Fagni1, Giulia Corte2, Axel Hueber4, Harriet Morf1, verena schönau1, Michael Sticherling5, eva manger1, sonja liehr1, Juergen Rech1, Georg Schett6, Arnd Kleyer7 and Anna-Maria Liphardt1, and Birte Coppers and Sara Bayat, 1Department of Internal Medicine 3 - Rheumatology and Immunology, Friedrich-Alexander University (FAU) Erlangen-Nürnberg and Universitätsklinikum Erlangen, Erlangen, Germany, Deutsches Zentrum für Immuntherapie (DZI), Friedrich Alexander University Erlangen-Nuremberg and Universitätsklinikum Erlangen, Erlangen, Germany, Erlangen, Germany, 2Department of Internal Medicine 3 - Rheumatology and Immunology, Friedrich-Alexander University (FAU) Erlangen-Nürnberg and Universitätsklinikum Erlangen, Erlangen, Germany, Deutsches Zentrum für Immuntherapie (DZI), Friedrich Alexander University Erlangen-Nuremberg and Universitätsklinikum Erlangen, Erlangen, Germany, Erlangen, Bayern, Germany, 3Charité - Universittsmedizin Berlin, Berlin, Germany, 4Klinikum Nuernberg, Nuernberg, Germany, 5FAU Erlangen-Nürnberg & Universitätsklinikum Erlangen, Department of Dermatology, Erlangen, Germany, Erlangen, Germany, 6Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany, 7Charité - Universittsmedizin Berlin, Erlangen, Germany

    Background/Purpose: Patients with skin psoriasis (Pso) have an increased risk of developing psoriatic arthritis (PsA) (6-42%) compared to the general population (0.02-0.42%) [1]. Early diagnosis…
  • Abstract Number: 2461 • ACR Convergence 2024

    Prevalence and Impact of Peripheral Neuropathy in SSc: A Frequent and Disabling Manifestation in SSc, and a Potential Surrogate Marker for Autonomic Neuropathy

    Begonya Alcacer-Pitarch1, marco di battista2, Anthony C. Redmond3, Anne-Maree Keenan4, Stefano Di Donato5, Francesco Del Galdo3 and Maya H. Buch6, 1Institute of Rheumatic and Musculoskeletal Medicine, Leeds, United Kingdom, 2Rheumatology Unit, University of Pisa, Pisa., Pisa., Italy, 3University of Leeds, Leeds, United Kingdom, 4School of Healthcare, university of leeds, leeds, United Kingdom, 5Leeds Institute of Rheumatic and Musculoskeletal Medicine, Chapel Allerton Hospital, Leeds, UK, Leeds, United Kingdom, 6Division of Musculoskeletal & Dermatological Sciences, University of Manchester, and NIHR Manchester Biomedical Research Centre, Manchester, United Kingdom

    Background/Purpose: SSc patients have high disability and low quality of life (QoL), driven partially by poor physical function (PF), Gastro Intestinal (GI) problems, digital ulcers…
  • Abstract Number: 0190 • ACR Convergence 2024

    Socioeconomic Disparities in Functional Status by Neighborhood Deprivation in a National Sample of Patients with Systemic Lupus Erythematosus

    Baljeet Rai1, Jessica Fitzpatrick2, Jing Li3, Gabriela Schmajuk4 and Jinoos Yazdany5, 1University of California, San Francisco, Modesto, CA, 2University California, San Francisco, San Francisco, CA, 3University of California, San Francisco, San Francisco, CA, 4UCSF / SFVA, San Francisco, CA, 5University of California San Francisco, San Francisco, CA

    Background/Purpose: Individuals with SLE can experience significant declines in functional status (FS). The ACR has recently identified physical function as a high-priority domain in SLE…
  • Abstract Number: 0449 • ACR Convergence 2024

    Evaluating Premenstrual Dysphoric Disorder in Women with Rheumatoid Arthritis and Healthy Female Subjects

    Ana Cecilia Bardan-Inchaustegui1, Iris Jazmín Colunga Pedraza2, Rosa Icela Arvizu-Rivera2, Gisela Garcia-Arellano3, Griselda Serna-Peña4, Maria F. Elizondo-Benitez5, Aleydis Gonzalez Melendez2, Fernanda Massiel Garcia6 and Dionicio Galarza-Delgado7, 1Universidad Autónoma de Nuevo León, Monterrey, Nuevo León, Mexico, 2Division of Rheumatology, University Hospital "Dr. Jose Eleuterio Gonzalez", Universidad Autonoma de Nuevo Leon, Monterrey, Mexico, 3Hospital Universitario \"Dr. José Eleuterio González\", Monterrey, Nuevo León, Mexico, 4Hospital Universitario "Dr. José Eleuterio González", UANL, Monterrey, Mexico, 5Division of Rheumatology, University Hospital "Dr. Jose Eleuterio Gonzalez", Universidad Autonoma de Nuevo Leon, Monterrey, Nuevo León, Mexico, 6Hospital Universitario Dr José Eleuterio González, Monterrey, Nuevo León, Mexico, 7UANL Hospital Universitario, Monterrey, Nuevo León, Mexico

    Background/Purpose: Premenstrual dysphoric disorder (PMDD), a severe form of premenstrual syndrome, is classified as a psychiatric disorder characterized by moderate to severe physical, affective, or…
  • Abstract Number: 0495 • ACR Convergence 2024

    Correlation Between Triglyceride/Glucose Index and Functional Capacity in Rheumatoid Arthritis Patients

    Yelitza Cecilia Velarde Mejia1, Manuel Ugarte-Gil2, Risto Perich3, Cesar Pastor4, Graciela Alarcon5 and RV, Gamboa-Cardenas6, 1Hncase, Arequipa, Peru, 2Universidad Cientifica del Sur, Lima, Lima, Peru, 3Hospital Almenara, Lima, Peru, 4UNMSM, LIMA, Peru, 5The University of Alabama at Birmingham, Oakland, CA, 6Universidad Científica del Sur, Lima, Lima, Peru

    Background/Purpose: The triglyceride/glucose index (TGI) is a metabolic marker associated with insulin resistance and cardiovascular risk. In patients with Rheumatoid Arthritis (RA), chronic inflammation and…
  • Abstract Number: 0569 • ACR Convergence 2024

    The Longitudinal Association Between Disease Activity, Function and Health-Related Quality of Life in Axial Spondyloarthritis: Results from the DESIR Cohort

    Augusta Ortolan1, Desiree van der Heijde2, Laure Gossec3 and Sofia Ramiro4, 1Policlinico Universitario Agostino Gemelli IRCSS, Rome, Lazio, Italy, 2Department of Rheumatology, Leiden University Medical Center, Meerssen, Netherlands, 3Sorbonne Université, Paris, France, 4Leiden University Medical Center, Bunde, Netherlands

    Background/Purpose: Health-related quality of life (HRQoL) in axSpA is considered an overarching outcome, with other disease outcomes contributing to it [1]. To validate a previously…
  • Abstract Number: 0720 • ACR Convergence 2024

    Impact of Systemic Vasculitides on Sexual Function: An Overlooked Aspect of Patient Care

    javier Merayo Chalico1, Ana Sarahí Mulia-Soto2, María Espinosa-León3, Victor Pimentel-Quiroz4, Ana Barrera-Vargas3 and Andrea Hinojosa-Azaola3, 1Department of Immunology and Rheumatology, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico, CDMX, Mexico, 2Department of Immunology and Rheumatology, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico, Ciudad de México, Mexico, 3Department of Immunology and Rheumatology, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico, Mexico City, Mexico, 4Universidad Científica del Sur/Hospital Nacional Guillermo Almenara Irigoyen, Magdalena del Mar, Peru

    Background/Purpose: Systemic vasculitides comprise a group of inflammatory diseases involving multiple organ systems, significantly affecting various aspects of a patient's life, including their sexuality. Sexual…
  • Abstract Number: 0819 • ACR Convergence 2023

    Regression to the Mean for Physical Function and Quality of Life in Trials for Symptomatic Knee Osteoarthritis

    Martin Englund and Aleksandra Turkiewicz, Lund University, Lund, Sweden

    Background/Purpose: Improvement in pain reported in clinical trials for osteoarthritis (OA) is typically strongly depending on the regression-to-the-mean phenomenon. Regression to the mean has been…
  • Abstract Number: 1191 • ACR Convergence 2023

    A Phase 1b, Randomized, Double-Blind, Placebo-Controlled, Multiple-Dosing, Ascending-Dose Study Evaluating the Safety, Tolerability and Pharmacokinetics of XG004 Applied Topically in Participants with Osteoarthritis of the Knee

    Guang-Liang Jiang1 and Feng Xu2, 1Xgene Pharmaceutical Inc., Lexington, MA, 2Xgene Pharmaceutical Inc., Altos Hills, CA

    Background/Purpose: Globally osteoarthritis affects about 302 million patients, knee osteoarthritis accounts for 263 million and ranks the highest in disability and pain compared to OA…
  • Abstract Number: 1274 • ACR Convergence 2023

    Rheumatoid Arthritis Patients, Achieving Low Disease Activity State or Remission, Still Demonstrate Significant Hand Disability, as Assessed by Functional Dexterity Test: A Disconnection Between CDAI and Functional Hand Assessment

    Aniela Shouval1, Amihai Levkovitch2, Itzhak Rosner3, shiri keret4, Irina Rokhyan2, Boris Tchalabian2, Esther Hof5 and Gleb Slobodin6, 1Bnai Zion Medical Center, Haifa, Israel, 2Department of Rehabilitation, Bnai Zion Medical Center, Haifa, Israel, 3Bnai Zion Medical Center/Technion, Haifa, Israel, 4Bnai Zion, Atlit, Israel, 5Occupational Therapy Unit, Bnai zion Medical Center, Haifa, Israel, 6Rheumatology Unit, Bnai Zion Medical Center, Haifa, Israel

    Background/Purpose: Direct functionality of the hand is not commonly assessed in daily practice or clinical trials in patients with rheumatoid arthritis (RA). Functional dexterity test…
  • Abstract Number: 1295 • ACR Convergence 2023

    Having More Tender Than Swollen Joints Is Associated with Worse Functional Outcomes in Patients with Early RA in a Prospective Real-World Cohort

    Charis Meng1, Yvonne Lee2, Orit Schieir3, Marie-France Valois4, Margaret Butler1, Gilles Boire5, Glen Hazelwood6, Carol Hitchon7, Edward Keystone8, Diane Tin9, Carter Thorne10, Louis Bessette11, Janet Pope12, Susan Bartlett13 and Vivian Bykerk1, 1Hospital for Special Surgery, New York, NY, 2Northwestern University, Chicago, IL, 3McGill University, Montréal, QC, Canada, 4McGill University, Pointe-Claire, QC, Canada, 5Université de Sherbrooke, Sherbrooke, QC, Canada, 6University of Calgary, Calgary, AB, Canada, 7University of Manitoba, Manitoba, MB, Canada, 8Keystone Consulting Enterprises Inc., Toronto, ON, Canada, 9Centre of Arthritis Excellence, Newmarket, ON, Canada, 10Southlake Regional Health Centre, Newmarket, ON, Canada, 11Centre de l'Ostéoporose et de Rhumatologie de Québec, Quebec City, QC, Canada, 12University of Western Ontario, London, ON, Canada, 13McGill University, Montreal, QC, Canada

    Background/Purpose: Early RA patients may present with more tender than swollen joints, which can persist during DMARD therapy. Elevated TSJD (tender-swollen joint difference) is often…
  • Abstract Number: 1304 • ACR Convergence 2023

    Window of Opportunity to Achieve Better Functional Outcomes in Patients with RA: Effectiveness of an Early Treatment Strategy

    Vivian Bykerk1, Isabel Castrejon2, Vibeke Strand3, Stephanie Dahan4, Raul Castellanos-Moreira5, Leo Chen6 and Wayne Little4, 1Department of Rheumatology, Hospital for Special Surgery, New York, NY, 2Hospital Universitario Gregorio Marañón, Madrid, Spain, 3Stanford University, Palo Alto, CA, 4Bristol Myers Squibb, Princeton, NJ, 5Bristol Myers Squibb, Madrid, Spain, 6Syneos Health, Vancouver, BC, Canada

    Background/Purpose: RA is a chronic disease that can lead to irreversible damage and functional decline with delayed or inadequate treatment.1 Abatacept + MTX is effective…
  • Abstract Number: 1384 • ACR Convergence 2023

    Functional Status by Sex and Socioeconomic Status in Axial Spondyloarthritis

    Rachael Stovall1, Jing Li1, zara izadi1, Lianne Gensler2, Gabriela Schmajuk3 and Jinoos Yazdany4, 1University of California San Francisco, San Francisco, CA, 2University of California San Francisco, Department of Medicine, Division of Rheumatology, San Francisco, CA, 3UCSF / SFVA, San Francisco, CA, 4University of California, General Department of Medicine, Division of Rheumatology, San Francisco, CA

    Background/Purpose: Women with axial spondyloarthritis (axSpA) tend to have worse patient reported outcomes compared to men. Non-U.S. studies have evaluated functional status (FS) by sex…
  • Abstract Number: 1408 • ACR Convergence 2023

    Impact of Disease Activity on Functional Impairment in Patients with Spondyloarthritis Is Different According to the Degree of Radiographic Progression: Result from SNUH-AS Cohort

    Ji In Jung1, Ju Yeon Kim2, Jin Kyun Park3, Eun Young Lee3, Eun Bong Lee2 and Jun Won Park2, 1Division of Rheumatology, Department of Internal Medicine, Seoul National University Hospital, Seoul, South Korea, 2Seoul National University Hospital, Seoul, South Korea, 3Seoul National University College of Medicine, Seoul, South Korea

    Background/Purpose: Although previous studies suggested that physical functioning is largely driven by disease activity in patients with spondyloarthritis (SpA), its relationship to radiographic progression has…
  • Abstract Number: 1965 • ACR Convergence 2023

    Discordance Between Patient and Physician Perception of Disease Activity Among Patients with Idiopathic Inflammatory Myopathies: Results from the COVAD Study

    Mrinalini Dey1, Rudra Prosad Goswami2, Parikshit Sen3, Samuel Shinjo4, Nelly Ziade5, Ioannis Parodis6, Mrudula Joshi7, Marcin Milchert8, Abraham Edgar Gracia-Ramos9, Lorenzo Cavagna10, Vishwesh Agarwal11, Johannes Knitza12, Jessica Day13, Hector Chinoy14, COVAD Study Group15, Vikas Agarwal16, Rohit Aggarwal17 and Latika Gupta18, 1Queen Elizabeth Hospital, London, United Kingdom; University of Liverpool, Liverpool, United Kingdom, 2Department of Rheumatology, All India Institute of Medical Sciences, New Delhi, India, 3Maulana Azad Medical College, 2-Bahadurshah Zafar Marg, New Delhi, Delhi-110002, India., Dalhi, India, 4Faculdade de Medicina FMUSP, Universidade de Sao Paulo, São Paulo, Brazil, 5Saint-Joseph University, Beirut, Lebanon, 6Karolinska Institutet, Stockholm, Sweden, 7Byramjee Jeejeebhoy Government Medical College and Sassoon General Hospitals, Pune, India, 8Department of Internal Medicine, Rheumatology, Diabetology, Geriatrics and Clinical Immunology, Pomeranian Medical University in Szczecin, Szczecin, Poland, 9Department of Internal Medicine, General Hospital, National Medical Center "La Raza", Instituto Mexicano del Seguro Social, Av. Jacaranda S/N, Col. La Raza, Del. Azcapotzalco, C.P. 02990, Mexico City, Mexico, 10Fondazione IRCCS Policlinico San Matteo, Pavia, Italy, 11Mahatma Gandhi Missions Medical College, Lucknow, India, 12Department of Internal Medicine 3 Rheumatology and Immunology, Friedrich-Alexander-University Erlangen-Nürnberg, University Hospital Erlangen, Erlangen, Germany, 13Walter and Eliza Hall Institute, Melbourne, Australia, 14The University of Manchester, Sale, United Kingdom, 15-, -, 16Sanjay Gandhi Postgraduate Institute of Medical Sciences (SGPGIMS), Lucknow, India, 17University of Pittsburgh, Pittsburgh, PA, 18Royal Wolverhampton Trust, Wolverhampton/University of Manchester, United Kingdom

    Background/Purpose: Disease activity assessment is key in the management of patients with idiopathic inflammatory myopathies (IIM). However, patients' perception of disease may differ from clinicians.…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • …
  • 11
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology